96 related articles for article (PubMed ID: 20864138)
21. Molecular Subgroups of Glioblastoma- an Assessment by Immunohistochemical Markers.
Nagy Á; Garzuly F; Padányi G; Szűcs I; Feldmann Á; Murnyák B; Hortobágyi T; Kálmán B
Pathol Oncol Res; 2019 Jan; 25(1):21-31. PubMed ID: 28948518
[TBL] [Abstract][Full Text] [Related]
22. Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.
Toh CH; Castillo M
AJNR Am J Neuroradiol; 2017 Feb; 38(2):288-293. PubMed ID: 27856439
[TBL] [Abstract][Full Text] [Related]
23. The effect of WHO reclassification of necrotic anaplastic oligoastrocytomas on incidence and survival in glioblastoma.
Marucci G
J Neurooncol; 2011 Sep; 104(2):621-2. PubMed ID: 21229290
[TBL] [Abstract][Full Text] [Related]
24. [Determination of molecular glioblastoma subclasses on the basis of analysis of gene expression].
Dmitrenko VV; Ershov AV; Stetsiuk PI; Likhovid AP; Laptin IuP; Shvarts DR; Mekler AA; Kavsan VM
Tsitol Genet; 2014; 48(6):45-55. PubMed ID: 25536822
[TBL] [Abstract][Full Text] [Related]
25. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
[TBL] [Abstract][Full Text] [Related]
26. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
27. Heavily lipidized, calcified giant cell glioblastoma in an 8-year-old patient, associated with neurofibromatosis type 1 (NF1): report of a case with long-term survival.
Kroh H; Matyja E; Marchel A; Bojarski P
Clin Neuropathol; 2004; 23(6):286-91. PubMed ID: 15584213
[TBL] [Abstract][Full Text] [Related]
28. Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI.
Simões RV; Ortega-Martorell S; Delgado-Goñi T; Le Fur Y; Pumarola M; Candiota AP; Martín J; Stoyanova R; Cozzone PJ; Julià-Sapé M; Arús C
Integr Biol (Camb); 2012 Feb; 4(2):183-91. PubMed ID: 22193155
[TBL] [Abstract][Full Text] [Related]
29. [WHO classification of brain tumors: present and prospective].
Nakazato Y
Nihon Rinsho; 2005 Sep; 63 Suppl 9():93-8. PubMed ID: 16201506
[No Abstract] [Full Text] [Related]
30. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
[TBL] [Abstract][Full Text] [Related]
31. Gray zones in brain tumor classification: evolving concepts.
Trembath D; Miller CR; Perry A
Adv Anat Pathol; 2008 Sep; 15(5):287-97. PubMed ID: 18724102
[TBL] [Abstract][Full Text] [Related]
32. [Classification of the astrocytic gliomas. Brief comments].
Pérez-Ortiz L; Galarraga J; Gómez-Suárez H; Tamayo-Suárez JD
Rev Neurol; 2000 Dec 16-31; 31(12):1180-3. PubMed ID: 11205555
[TBL] [Abstract][Full Text] [Related]
33. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
34. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
35. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
36. Lipoglioblastoma: a lipidized glioma radiologically and histologically mimicking adipose tissue.
Johnson MW; Lin D; Smir BN; Burger PC
World Neurosurg; 2010 Feb; 73(2):108-11. PubMed ID: 20860936
[TBL] [Abstract][Full Text] [Related]
37. Update on diagnostic practice: tumors of the nervous system.
Pytel P; Lukas RV
Arch Pathol Lab Med; 2009 Jul; 133(7):1062-77. PubMed ID: 19642733
[TBL] [Abstract][Full Text] [Related]
38. Emerging insights into the molecular and cellular basis of glioblastoma.
Dunn GP; Rinne ML; Wykosky J; Genovese G; Quayle SN; Dunn IF; Agarwalla PK; Chheda MG; Campos B; Wang A; Brennan C; Ligon KL; Furnari F; Cavenee WK; Depinho RA; Chin L; Hahn WC
Genes Dev; 2012 Apr; 26(8):756-84. PubMed ID: 22508724
[TBL] [Abstract][Full Text] [Related]
39. Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data.
Marko NF; Quackenbush J; Weil RJ
PLoS One; 2011; 6(7):e20826. PubMed ID: 21829433
[TBL] [Abstract][Full Text] [Related]
40. Histologic factors of prognostic significance in the glioblastoma multiforme.
Burger PC; Vollmer RT
Cancer; 1980 Sep; 46(5):1179-86. PubMed ID: 6260329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
